Opus Genetics, Inc. — Net Income by Fiscal Year
24 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8da2cd48-2d11-4389-b4dd-03bdb7ea38f3/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-49.6M | 2025-01-01 – 2025-12-31 | evidence 0001140361-26-009247 |
| FY 2024 | $-57.5M | 2024-01-01 – 2024-12-31 | evidence 0001140361-25-011410 |
| FY 2023 | $-10.0M | 2023-01-01 – 2023-12-31 | evidence 0001140361-24-012399 |
| FY 2022 | $17.9M | 2022-01-01 – 2022-12-31 | evidence 0001140361-23-014868 |
| FY 2021 | $-56.7M | 2021-01-01 – 2021-12-31 | evidence 0001140361-22-011015 |
| FY 2020 | $-24.6M | 2020-01-01 – 2020-12-31 | evidence 0001140361-21-008099 |
| FY 2019 | $-6.2M | 2019-01-01 – 2019-12-31 | evidence 0001140361-21-008099 |
| FY 2018 | $-14.4M | 2018-01-01 – 2018-12-31 | evidence 0001140361-19-004539 |
| FY 2017 | $-25.3M | 2017-01-01 – 2017-12-31 | evidence 0001140361-18-012817 |
| FY 2016 | $-9.3M | 2016-01-01 – 2016-12-31 | evidence 0001140361-17-009132 |
| FY 2015 | $-14.4M | 2015-01-01 – 2015-12-31 | evidence 0001140361-16-057543 |
| FY 2014 | $-18.5M | 2014-01-01 – 2014-12-31 | evidence 0001140361-15-011969 |
| FY 2013 | $-87.4M | 2001-03-19 – 2014-03-31 | evidence 0001140361-14-020971 |
| FY 2012 | $-64.8M | 2001-03-19 – 2013-03-31 | evidence 0001140361-13-019748 |
| FY 2011 | $-59.2M | 2001-03-19 – 2012-03-31 | evidence 0001140361-12-023967 |
| FY 2010 | $-14.0M | 2010-01-01 – 2010-12-31 | evidence 0001140361-12-016054 |
| FY 2009 | $-2.9M | 2009-01-01 – 2009-12-31 | evidence 0001140361-12-016054 |
| FY 2008 | $-3.7M | 2008-01-01 – 2008-12-31 | evidence 0001140361-13-013730 |
| FY 2007 | $-4.4M | 2007-01-01 – 2007-12-31 | evidence 0001140361-13-013730 |
| FY 2006 | $-6.5M | 2006-01-01 – 2006-12-31 | evidence 0001140361-13-013730 |
| FY 2005 | $-6.3M | 2005-01-01 – 2005-12-31 | evidence 0001140361-13-013730 |
| FY 2004 | $-3.3M | 2004-01-01 – 2004-12-31 | evidence 0001140361-13-013730 |
| FY 2003 | $-2.8M | 2003-01-01 – 2003-12-31 | evidence 0001140361-13-013730 |
| FY 2002 | $-1.2M | 2002-01-01 – 2002-12-31 | evidence 0001140361-13-013730 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Opus Genetics, Inc. — all facts · Revenue · Operating Income